umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Urology and Andrology. Department of Urology, Uppsala University Hospital, Uppsala, Sweden.
2016 (English)In: Journal of Urology, ISSN 0022-5347, E-ISSN 1527-3792, Vol. 195, no 4, 1172-1173 p.Article in journal, Letter (Refereed) Published
Resource type
Text
Place, publisher, year, edition, pages
Elsevier, 2016. Vol. 195, no 4, 1172-1173 p.
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:umu:diva-119646ISI: 000373401200122OAI: oai:DiVA.org:umu-119646DiVA: diva2:929213
Available from: 2016-05-18 Created: 2016-04-25 Last updated: 2016-05-18Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Stattin, Pär
By organisation
Urology and Andrology
In the same journal
Journal of Urology
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar

Total: 12 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf